-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Reinstates Buy on Filana Therapeutics, Announces $5 Price Target

Benzinga·05/26/2026 19:53:48
Listen to the news
Maxim Group analyst Jason McCarthy reinstates Filana Therapeutics (NASDAQ:FLNA) with a Buy and announces $5 price target.